TY - JOUR
T1 - Anthropometric Measures, Physical Activity, and Risk of Glioma and Meningioma in a Large Prospective Cohort Study
AU - Michaud, Dominique S.
AU - Bove, Gerald
AU - Gallo, Valentina
AU - Schlehofer, Brigitte
AU - Tjonneland, Anne
AU - Olsen, Anja
AU - Overvad, Kim
AU - Dahm, Christina C.
AU - Teucher, Brigit
AU - Boeing, Heiner
AU - Steffen, Annika
AU - Trichopoulou, Antonia
AU - Bamia, Christina
AU - Kyrozis, Andreas
AU - Sacerdote, Carlotta
AU - Agnoli, Claudia
AU - Palli, Domenico
AU - Tumino, Rosario
AU - Mattiello, Amalia
AU - Bueno-de-Mesquita, H. Bas
AU - Peeters, Petra H. M.
AU - May, Anne M.
AU - Barricarte, Aurelio
AU - Chirlaque, Maria-Dolores
AU - Dorronsoro, Miren
AU - Jose Sanchez, Maria
AU - Rodriguez, Laudina
AU - Duell, Eric J.
AU - Hallmans, Goran
AU - Melin, Beatrice S.
AU - Manjer, Jonas
AU - Borgquist, Signe
AU - Khaw, Kay-Tee
AU - Wareham, Nick
AU - Allen, Naomi E.
AU - Travis, Ruth C.
AU - Romieu, Isabelle
AU - Vineis, Paolo
AU - Riboli, Elio
N1 - ©2011 AACR.
PY - 2011/9
Y1 - 2011/9
N2 - Body fatness has been associated with increased risk of a number of hormone-dependent cancers. Recent studies suggest that body mass index (BMI) may be related to meningiomas, which are more common in women than men, and for which estrogens are believed to play a role. Using data from a large European propective cohort, 203 incident cases of meningioma and 340 cases of glioma were included in the analysis for measures of body fat, height, and physical activity among 380,775 participants. All analyses were conducted using Cox proportional hazards model and controlling for age, sex, country, and education. A 71% increase in risk of meningioma was observed among men and women in the top quartile of waist circumference (HR = 1.71, 95% CI = 1.08-2.73, P-trend = 0.01). A positive association was also observed for BMI and meningioma (HR = 1.48, 95% CI = 0.98-2.23, for BMI >= 30 compared with a BMI of 20-24.9, P-trend = 0.05). An association with height and meningioma was also suggestive (HR = 1.24, 95% 0.96-1.51, for each 10 cm increase). In contrast, no associations were observed for height and different measures of body fat and risk of glioma. Physical activity was not related to either type of brain tumors. Results from this study support an increase in risk of meningioma with higher body fatness among both men and women. No association was observed between anthropometric measures and risk of glioma. Cancer Prev Res; 4(9); 1385-92. (C) 2011 AACR.
AB - Body fatness has been associated with increased risk of a number of hormone-dependent cancers. Recent studies suggest that body mass index (BMI) may be related to meningiomas, which are more common in women than men, and for which estrogens are believed to play a role. Using data from a large European propective cohort, 203 incident cases of meningioma and 340 cases of glioma were included in the analysis for measures of body fat, height, and physical activity among 380,775 participants. All analyses were conducted using Cox proportional hazards model and controlling for age, sex, country, and education. A 71% increase in risk of meningioma was observed among men and women in the top quartile of waist circumference (HR = 1.71, 95% CI = 1.08-2.73, P-trend = 0.01). A positive association was also observed for BMI and meningioma (HR = 1.48, 95% CI = 0.98-2.23, for BMI >= 30 compared with a BMI of 20-24.9, P-trend = 0.05). An association with height and meningioma was also suggestive (HR = 1.24, 95% 0.96-1.51, for each 10 cm increase). In contrast, no associations were observed for height and different measures of body fat and risk of glioma. Physical activity was not related to either type of brain tumors. Results from this study support an increase in risk of meningioma with higher body fatness among both men and women. No association was observed between anthropometric measures and risk of glioma. Cancer Prev Res; 4(9); 1385-92. (C) 2011 AACR.
KW - BRAIN-TUMORS
KW - CANCER
KW - HEIGHT
KW - WEIGHT
KW - GROWTH
KW - OVERWEIGHT
KW - MORTALITY
KW - VALIDITY
KW - OBESITY
KW - LIFE
U2 - 10.1158/1940-6207.CAPR-11-0014
DO - 10.1158/1940-6207.CAPR-11-0014
M3 - Article
C2 - 21685234
SN - 1940-6207
VL - 4
SP - 1385
EP - 1392
JO - Cancer Prevention Research
JF - Cancer Prevention Research
IS - 9
ER -